Does Dr. TIFFANY COLAVINCENZO have financial conflicts of interest?

Dr. TIFFANY COLAVINCENZO (AGACNP) has received a total of $180 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $180 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TIFFANY COLAVINCENZO?

According to CMS Open Payments data, Dr. TIFFANY COLAVINCENZO received funding from JANSSEN PHARMACEUTICALS ($104) and ASTRAZENECA PHARMACEUTICALS ($76).

Does Dr. TIFFANY COLAVINCENZO receive research grants or speaking fees?

Dr. TIFFANY COLAVINCENZO has received $180 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. TIFFANY COLAVINCENZO

AGACNPReal-Time Hydrated

Specialty: Nurse Practitioner, Acute Care

Practice Location: CHARLOTTESVILLE, VA 22908

NPI Number: 1124621586

LIFETIME INDUSTRY VALUE

$180

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. COLAVINCENZO is a verified Nurse Practitioner, Acute Care practitioner based in CHARLOTTESVILLE, VA.

Between 2021 and 2024, Dr. COLAVINCENZO had an overall industry promotional and research financial footprint of $180 as recorded in the federal CMS Open Payments database.

$180 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. COLAVINCENZO's primary funding source is JANSSEN PHARMACEUTICALS, which accounts for $104 (representing 57.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN PHARMACEUTICALS

Rank 1

$104

57.6%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$76

42.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.